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Abstract
Background: In the 1990s, China introduced a “free” tuberculosis (TB) care policy under the national TB control
program. Recently, as a part of a new TB diagnosis and treatment model, it has been recommended that the
integrated model scale up. This paper examines whether or not TB designated hospitals in the selected project
sites have provided TB care according to the national and local guidelines, and analyzes the actual practices and
expenditures involved in completing TB treatment. It also explores the reasons why “free” TB care in China cannot
be effectively implemented under the integrated model.
Methods: This study was conducted in three counties of Zhenjiang city, Jiangsu province. Mixed methods were
used, which comprised reviewing the national and local TB control guidelines, conducting TB patient surveys,
collecting TB inpatient and outpatient hospital records, and conducting qualitative interviews with stakeholders.
Descriptive statistics were used for quantitative data analysis across counties and in order to compare patients
who received only outpatient care and those who received both outpatient and inpatient care. The chi-square test
and analysis of variance were performed where necessary. Qualitative data were analyzed using the framework
approach.
Results: Although the national TB care guidelines recommend outpatient care as a basis for TB treatment in China,
we found high hospital admission rates for TB patients ranging from 39 % in Yangzhong county to 83 % in Dantu
county. Almost all outpatient TB patients paid for lab tests and over 80 % paid for liver protection drugs and
around 70 % paid for image examinations. These three components accounted for three-quarters of the total
outpatient expenditure. For patients who received only outpatient care, the total expenditure upon completion of
TB treatment was on average 1,135 Chinese yuan. For patients who received outpatient and inpatient care, the
total expenditure upon completion of TB treatment was 11,117 Chinese yuan.
Conclusion: The “free” TB care policy under the integrated model has not been effectively implemented in China.
There has been substantial spending on non-recommended services, examinations, and drugs for TB treatment.
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Background
Tuberculosis (TB) remains a serious public health issue
worldwide. China has the world’s second largest TB
epidemic with an estimate of one million new cases re-
ported in 2013, which accounted for 11.6 % of the global
incidence [1].
Fighting against TB has gained high political commit-
ment in China. In the 1990s, China initiated an innova-
tive national TB control program (NTP) with the World
Health Organization (WHO)-recommended directly ob-
served treatment, short-course (DOTS) strategy funded
by a World Bank loan and the Chinese Ministry of
Health (now called the National Health and Family Plan-
ning Commission of China, NHFPC) [2, 3]. To remove
financial barriers to access to standard TB diagnosis and
treatment, especially for the poor, healthcare providers
in general health facilities are required to refer TB sus-
pects to local TB dispensaries for diagnosis based on
smear microscopy and radiography free of charge. Pa-
tients diagnosed with smear-positive or severe smear-
negative TB could be treated with free first-line anti-TB
drugs at TB dispensaries [4]. This policy has gradually
been extended to cover all smear-negative TB patients,
and was expanded to the entire country by 2005 [3] as
part of the “free” TB diagnosis and treatment policy.
From 1990 to 2010, China has more than halved its
TB prevalence, which is largely attributed to the DOTS
program and the free TB treatment policy [2]. The
WHO called China’s NTP-DOTS program “one of the
most successful DOTS programs in the world.” But al-
though TB prevalence has dropped significantly, there is
still a heavy TB burden in China. The 2010 national TB
epidemiology survey reported that the prevalence of ac-
tive pulmonary TB was 459 per 100,000 population, and
the prevalence of TB in rural areas was almost twice that
of urban areas [5]. What’s more, the convergence of TB
management systems—which authorize only TB dis-
pensaries and/or TB centers to provide TB diagnosis,
treatment, and case management—have faced challenges
regarding the treatment of multidrug-resistant TB and
other TB-related complications [6]. In the late 1990s, a
new model called the “integrated model” was piloted
and carried out in some eastern provinces (Shanghai,
Zhejiang, and Jiangsu) and a few sites in western China
[7]. It encompassed the setup of TB clinics in general
hospitals to provide standard TB care and case manage-
ment in cooperation with local TB dispensaries. All TB
patients are diagnosed and treated in designated hospi-
tals and the local TB dispensaries are mainly in charge
of TB public health care including health education,
training and supervision. It is now recommended that
this model scales up.
Despite gains in TB control, evidence has shown that
there are substantial costs associated with TB diagnosis
and treatment, and that TB patients face a heavy finan-
cial burden, even under the “free” TB care policy [8–11].
Many previous studies found that TB patients were
charged for longer treatment periods than recom-
mended, and drugs and tests were administered beyond
the standard treatment regimen, all largely attributed to
perverse financial incentives of TB care providers [12].
Although TB diagnosis and treatment has shifted to TB
designated hospitals, little is known about the imple-
mentation of the national TB care policy and the costs
of TB care in these hospitals.
The main objectives of this paper are to examine
whether or not TB designated hospitals in the selected
project sites have provided TB care according to the na-
tional and local practice guidelines, and to determine
the actual practices and costs involved in completing TB
treatment. The paper also explores the reasons why “free”




For the purpose of this study, we used data collected
from Zhenjiang city, which is a prefectural city consist-
ing of several urban districts and county-level cities (we
refer to these as “counties” in this paper), in Jiangsu
province. Zhenjiang was selected as it is one of the pro-
ject cities of the China NHFPC and the Gates Founda-
tion TB Project (China-Gates TB project for short)
Phase II. In 2002, the integrated model was initiated in
counties in Zhenjiang. All county general hospitals were
authorized to act as TB designated hospitals; that is, they
were in charge of the diagnosis and treatment of TB pa-
tients who lived in the respective counties. Data collec-
tion was carried out in Jurong (JR), Dantu (DT), and
Yangzhong (YZ) counties, which were selected according
to their gross domestic product per capita in 2012, and
classified as low, middle and high income, respectively
(54,140 yuan in JR, 83,388 yuan in DT, 105,879 yuan in
YZ). The integrated model was implemented in DT
county in 2002, and in the YR and JR counties in 2011.
Data collection
A mixed method was used to collect the data. Both
quantitative and qualitative methods were incorporated
to complement each other, making the study more
comprehensive.
Firstly, we collected the national and local TB diagnosis
and treatment practice guidelines from the TB designated
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hospitals that were focused on the free TB care policy
to examine whether TB care providers adhered to the
guidelines.
Secondly, a patient survey was carried out in the three
selected counties to investigate the use of and expendi-
tures associated with TB care. A cluster random sam-
pling method was adopted based on townships and
streets to recruit TB cases who started a TB treatment
course in 2012 and completed or stopped treatment be-
fore the commencement of the survey (April 2013). In
each county, three townships/streets were randomly se-
lected and, in each of those, 30 TB cases were randomly
sampled from the TB case registration list. We sampled
a few TB cases from 2011 when the TB cases from 2012
didn’t fulfill the sample size requirement. In total,
267 TB patients were identified and interviewed using a
structured questionnaire by trained medical students
from Nanjing Medical University. The questionnaires
collected information on: patient demographic and social
factors, TB-related diagnostic and treatment pathways/
histories, direct health service expenditures and indirect
expenses (e.g. transportation and accommodation costs,
lost household income, etc.), and reimbursements from
health insurance agencies. After data cleaning, there were
263 valid, completed questionnaires.
Thirdly, complete medical records of the sampled
patients were obtained from their respective county’s
designated hospital. We used patients’ names as a key
variable to find outpatient records of patients who com-
pleted a full course of TB treatment. Tuberculosis in-
patient records from 2010 to 2012 were also collected.
Both inpatient and outpatient records included informa-
tion on frequency of care use, services used (e.g. labora-
tory and X-ray examinations, and drug regimens and
prescriptions), and itemized expenditures. Fees for ser-
vices covered by the free TB care policy were directly
deducted and not recorded in the patients’ medical
records.
In addition, qualitative interviews were conducted with
stakeholders in the selected three counties to explore
their perceptions about adherence to TB practice guide-
lines, especially how it relates to the implementation of
the free TB care policy in the designated hospitals. These
consisted of key informant interviews (KII) and focus
group discussions (FGDs). Semi-structured KIIs were
conducted with local health administrators, Center for
Disease Control and Prevention (CDC) heads who were
in charge of TB control, CDC TB control unit leaders,
heads of TB designated hospitals, and local health insur-
ance managers; 15 individual interviews were conducted.
The KIIs wanted to elucidate information on the finan-
cial burden of TB patients, health insurance regulations
on service provision, and payment methods for TB treat-
ment. The FGDs were carried out with TB care providers
in the county designated hospitals; three FGDs were con-
ducted. Each focus group had eight to ten participants,
comprising doctors (two to three) and nurses (two to
three) who treat TB, the head of the TB unit, lab staff (one
to two), and administrative staff (one to two) who worked
in TB diagnosis and treatment. The FGDs wanted to eluci-
date information on patient treatment adherence, doctor/
nurse incomes and bonuses compared to their counter-
parts in other departments, career development opportun-
ities, job perception and satisfaction, TB diagnosis and
treatment practices, and how participants perceived the
provision of TB diagnosis and treatment.
Data analysis
We reviewed the national and local TB care practice
guidelines and summarized information pertaining to
DOTS implementation, services used (e.g. laboratory
and X-ray examinations, and drug regimens and pre-
scriptions), and the free TB care policy.
In terms of quantitative data, we linked the patient
surveys (263 cases) with the patients’ respective hospital
records in order to acquire precise information on the
use of and expenditure relating to full-course TB treat-
ment. We successfully matched 200 cases (hereinafter
referred to as a “linked dataset”). The four indicators we
examined were: 1) hospital admission rate, calculated by
the number of admitted TB patients as a proportion of
the total number of TB patients undertaking the survey;
2) frequency of outpatient visits based on the linked
dataset; 3) proportion of patients paying for lab tests (in-
cluding blood, urine, liver function, or kidney function
tests, etc.), and image examinations (including chest
radiography, X-ray examination, and CT); and 4) pro-
portion of patients paying for non-free anti-TB drugs
and liver protection drugs according to the linked data-
set. The total medical expenditures upon completing TB
treatment were determined based on the hospital re-
cords in the linked dataset. Descriptive statistics were
used to examine TB care use and expenditures associ-
ated with TB care among patients who received only
outpatient care and those who received both outpatient
and inpatient care. Itemized expenditures relating to
outpatient care among patients who received only out-
patient care were also examined.
Data collected using qualitative methods were re-
corded and transcribed, and then analyzed using the
framework approach. The framework was developed
based on the topic guide and categories that emerged
from the transcripts, and was used to identify themes.
All qualitative data were coded, sorted, and classified in
terms of this framework. Charting was used to identify
common and divergent perceptions, and explanations
were developed. The NVivo 10 software package was
used to manage data.
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Ethical considerations
The study design and implementation of the China-
Gates TB project Phase II was approved by the Research
Ethics Committee of the China CDC. All data were col-
lected with the informed consent of participants prior to
their participation in the study. Data access complied
with standard procedures.
Results
National and local TB care practice guidelines
The national TB care practice guidelines [4] recommend
that TB treatment predominantly consists of outpatient
care for six to eight months. Tuberculosis patients are
urged to visit TB designated facilities once a month to
take anti-TB drugs and undergo recommended tests and
examinations. Specifically, it is recommended that spu-
tum smear tests are conducted by the end of the second,
fifth, and sixth months of treatment (for new patients),
or the eighth month of treatment (for relapsed patients).
In addition, routine blood, urine, and liver function tests
are recommended at treatment initiation. By the end of
the first month of treatment, routine blood and urine
tests are also recommended. Liver function tests can be
performed if necessary (e.g. if side effects are reported
by patients in relation to abnormal liver function). X-ray
examination is recommended at treatment initiation, by
the end of the first month of treatment, and at the end
of the treatment. During treatment, it’s only necessary
for TB patients with severe complications to be admitted
to hospital. Across the full course of treatment, two
X-ray examinations, three sputum smear tests, and first-
line anti-TB drugs are provided free of charge.
In addition to the national “free” TB policy, two liver
function tests and one or two chest radiographies are
free of charge for TB patients in Zhenjiang. Fixed-dose
combinations (FDCs) of the first-line anti-TB drugs are
commonly used. In DT county, township doctors collect
anti-TB drugs from the TB designated hospital every
two months, allowing TB patients to take their drugs
and conduct their tests in township health centers.
Comparison between the patient surveys (263 cases) and
the linked dataset (200 cases)
Two hundred and sixty-three TB patients participated in
the patient survey, however, only 200 complete medical
records were successfully obtained from hospitals. Out
of the 200 patients with complete medical records, 106
received only outpatient care and 94 received both
outpatient and inpatient care. After comparing the two
datasets, no significant differences were found in respect
to age, gender, type of residence, type of health insurance,
or hospital admission rate (p = 0.870, p = 0.999, p = 0.649,
p = 0.435, and p = 0.116, respectively). This means that how
these 200 patients use TB care and the costs associated
with completing treatment can represent the entire cohort
of 263 patients. Therefore, we used a linked dataset (200
cases) to examine outpatient care utilization and precise
expenditure on completing TB treatment.
Characteristics of TB patients
Table 1 presents the demographic and social characteris-
tics of the surveyed TB patients. Of the 263 patients,
193 were new patients and 70 were relapsed patients.
The majority of TB patients were rural residents (89.4 %)
and male (73 %), and more than half were over 60 years of
age (57.4 %). Almost all patients had health insurance
coverage; 82 % were covered by the New Cooperative
Medical Scheme (NCMS), designed for the rural popu-
lation and oriented at inpatient services, implemented
by the central Chinese government. Similar results were
found across the three counties.
Utilization of TB care
Inpatient care
The patient survey revealed that half of the participating
TB patients had been admitted to hospital. The propor-
tion of hospital admission was highest in DT county
(83 %), followed by JR county (43 %) and YZ county
(39 %). The difference between the respective counties
was statistically significant (χ2 = 41.021, p < 0.0001). The
length of hospital stay was also longest in DT county
(33.4 days), compared to both JR and YZ counties
Table 1 Demographic and social characteristics of TB patients










<30 3.6 7.3 6.2 5.7
30–59 45.2 32.9 33.0 36.9
60+ 51.2 59.8 60.8 57.4
Sex
Male 69.0 74.4 75.3 73.0
Female 31.0 25.6 24.7 27.0
Type of residence
Rural 96.4 84.2 87.6 89.3
Urban 3.6 14.6 11.4 9.9
Unified residence (hukou)b 0.0 1.2 1.0 0.8
Health insurance
None 0.0 6.1 0.0 1.9
NCMS 89.3 68.3 86.6 81.7
Othera 10.7 25.6 13.4 16.4
Data source: TB patient survey
aOther included the Urban Employee Basic Medical insurance, the Urban
Residence Basic Medical insurance, and commercial health insurance
bhukou is the household registration system in China. It’s usually a
dichotomy—rural hukou or urban hukou. In rare cases, it may be unified
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(22 days). No statistically significant difference was ob-
served in the hospital admission rate between new TB
patients and relapsed patients (χ2 = 0.870, p = 0.401).
Local CDC staff and healthcare providers in county
TB designated hospitals had different opinions regarding
the high hospital admission rates. In all three counties,
almost all CDC heads in charge of TB control and TB
unit leaders thought that overprovisioning of services,
driven by financial incentives to TB designated hospitals,
resulted in the high hospital admission rates and in turn
increased the financial burden placed on TB patients. In
contrast, some healthcare providers in TB designated
hospitals thought smear-positive TB patients should be
admitted to hospital to reduce and/or avoid community
infection. Some explained that some TB patients asked
to be admitted, as they could then claim reimbursement
for hospital admission but could not claim for outpatient
care. In addition, some healthcare providers believed
that high hospital admission rates were partly attributed
to fear of malpractice and conflict with patients.
Outpatient care
According to the linked dataset, patients who only re-
ceived outpatient care on average visited the outpatient
department 7.5 times—more than those who received
both inpatient and outpatient care (see Table 2). The
frequency of outpatient visits was lowest in DT county,
followed by YZ county, and was the highest in JR
county. There was no statistically significant difference
observed in outpatient visits between new and relapsed
patients in all three counties (p = 0.889 in DT, p = 0.201
in YZ, p = 0.222 in JR). The high admission rate in DT
(83 %) and the practice where township doctors collect
anti-TB drugs from the county TB designated hospital
every two months and dispense them to patients is prob-
ably why so few patients seek outpatient care in DT
county.
In addition to the services covered by the national and
local free TB policies, almost all TB patients paid for lab
tests (including the practice guideline-recommended
and non-recommended tests), and a vast majority paid
for liver protection drugs in all three counties (see
Table 3). In addition, around 70 % of patients paid for
image examinations (e.g. CT). Of the patients who re-
ceived only outpatient care, nearly 40 % took non-free,
second-line anti-TB drugs, whereas the proportion of
patients taking non-free anti-TB drugs was much lower
for those who received both inpatient and outpatient
care (19.1 %).
Qualitative interviews explored perceptions of stake-
holders about outpatient care provision with a focus on
the free TB care policy. In the three counties, almost all
CDC staff, TB designated hospital managers, and health-
care providers expressed that only a few services were
covered by the free TB care policy, and “many necessary
tests and drugs, such as liver function tests and liver
protection drugs, among others, were not free and ex-
pensive.” Some CDC TB unit leaders mentioned that
“[doctors of] TB designated hospitals often performed
CT instead of X-ray examinations and prescribed non-
free anti-TB drugs,” which was perceived to be unneces-
sary and costly. Most healthcare providers in the TB des-
ignated hospitals said that their patients suffered from
side effects and this was the main reason for prescribing
non-free anti-TB drugs. Others added that it was diffi-
cult to address patients’ side effects caused by one orTable 2 Frequency of outpatient visits during a treatment
course among patients who received only outpatient care and
patients who received both outpatient and inpatient care by
county %, 2012
DT YZ JR Total
Receiving only outpatient care (n = 14) (n = 49) (n = 43) (n = 106)
1–3 78.6 0.0 20.9 18.9
4–6 7.1 36.7 14.0 23.6
7–9 14.3 51.0 16.3 32.1
10+ 0.0 12.3 48.8 25.4
(Mean) (2.9) (7.3) (9.3) (7.5)
Receiving both outpatient
and inpatient care
(n = 61) (n = 10) (n = 23) (n = 94)
1–3 83.6 10.0 8.7 57.4
4–6 8.2 60.0 17.4 16.0
7–9 1.6 20.0 17.4 7.4
10+ 6.6 10.0 56.5 19.2
(Mean) (3.1) (6.3) (11.4) (5.5)
Data source: Patient surveys and hospital records
Table 3 Proportion of patients paying for drugs, lab tests, and
examinations during outpatient visits by county (%), 2012
DT YZ JR Total
Receiving only outpatient care (n = 14) (n = 49) (n = 43) (n = 106)
- Non-free anti-TB drugs 42.9 36.7 41.9 39.6
- Liver protection drugs 64.3 85.7 83.7 82.1
- Image examinationa 85.7 77.6 53.5 68.9
- Lab testsb 100.0 98.0 100.0 99.1
Receiving outpatient and
inpatient care
(n = 61) (n = 10) (n = 23) (n = 94)
- Non-free anti-TB drugs 18.0 10.0 26.1 19.1
- Liver protection drugs 75.4 90.0 91.3 80.9
- Image examinationa 82.0 80.0 43.5 72.3
- Lab testsb 95.1 100.0 100.0 96.8
Data source: Patient surveys and hospital records
aImage examination included X-ray examination, chest radiography, and CT
bLab tests included blood test, urine test, liver function test, kidney function
test, etc
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two anti-TB drugs when FDC drugs were used. In
addition, several healthcare providers in the designated
hospitals expressed mistrust in the effectiveness and
quality of the free anti-TB drugs.
Expenditure associated with TB treatment
We analyzed expenditure associated with completing TB
treatment among patients who only received TB out-
patient care and those who received both outpatient and
inpatient care, using the hospital records in the linked
dataset. For patients who received only outpatient care,
the total expenditure upon completion of TB treatment
was on average 1,135 Chinese yuan and approximately
151 Chinese yuan per visit. Costs associated with lab
tests, image examinations, and liver protection drugs
accounted for three-quarters of the total expenditure.
Expenditure for outpatient TB treatment was highest in
JR county, followed by YZ county, and was lowest in DT
county (see Table 4). In terms of itemized expenditures,
image examinations in DT and YZ counties and liver
protection drugs in JR county accounted for around
one-third of the total expenditure. For patients who re-
ceived both outpatient and inpatient care, total expend-
iture upon completion of treatment was almost 10 times
that of expenditure associated with receiving only out-
patient care (see Table 5). Overall, the expenditure for
both outpatient and inpatient care in YZ county was
relatively lower than in DT and JR counties.
Qualitative interviews with health insurance managers
elucidated that most outpatient TB care services, includ-
ing lab tests, CT scans, and liver protection drugs, were
not covered by the NCMS. Tuberculosis patients paid
for outpatient care fully out-of-pocket in YZ, and largely
in DT and JR. Although health insurance managers in
the three counties said that health insurance schemes
usually covered 70–80 % of inpatient expenditure, aim-
ing to reduce the patients’ financial burden, some CDC
leaders indicated that many prescribed services and
drugs were not included in the benefit packages of the
health insurance schemes. Hence, the actual reimburse-
ment proportion was much lower, suggesting that patients
faced a heavy financial burden due to TB treatment.
Discussion
Our study showed that China’s NTP provides TB pa-
tients with “free” TB care for essential diagnosis and
treatment based on the national policies developed by
the central government.
However, the extent to which free TB care is being
provided varies from place to place, subject to local re-
sources and policies. This study revealed that the three
project counties in Jiangsu province offered more free
lab tests and chest radiographies than other counties in
China.
In the context of free essential TB care and near uni-
versal health coverage, TB patients should not experi-
ence much financial difficulty in accessing TB care.
Unfortunately, this study found that this is not the real-
ity for those seeking treatment under the integrated
model. First, the policies of the NCMS do not offer ad-
equate coverage of outpatient services, including TB
outpatient care. For one reason or another, the national
guidelines for developing NCMS policies, issued by the
central government in the early 2000s, requested local
authorities at county and city levels to prioritize cover-
age of inpatient services. However, a vast majority of TB
patients may only need TB diagnoses and treatment,
which can be provided at hospitals’ outpatient depart-
ments. Furthermore, Chinese hospitals often provide TB
Table 4 Medical expenditure on TB treatment (in Chinese yuan)










Expenditure per outpatient visit 233.8 155.9 137.4 150.6
Total expenditure per patienta 684.7 1,139.3 1,277.7 1,135.4
- Lab tests 266.6 253.7 361.8 299.3
(as a % of the total expenditure) 38.9 % 22.3 % 28.3 % 26.4 %
- Image examination 256.2 395.7 51.9 237.8
(as a % of the total expenditure) 37.4 % 34.7 % 4.1 % 20.9 %
- Non-free TB drugs 20.7 95.5 47.9 66.3
(as a % of the total expenditure) 3.0 % 8.4 % 3.8 % 5.8 %
- Liver protection drugs 87.8 288.2 452.3 328.3
(as a % of the total expenditure) 12.8 % 25.3 % 35.4 % 28.9 %
- Other 53.4 106.2 363.8 203.8
(as a % of the total expenditure) 7.8 % 9.3 % 28.5 % 18.0 %
Data source: Patient surveys and hospital records
aANOVA for total expenditure per patient between the three counties, p < 0.0001,
significant difference observed between DT county and JR county
Table 5 Medical expenditure on TB treatment (in Chinese yuan)
incurred by patients receiving both outpatient and inpatient










Expenditure per visit 209.4 195.2 167.7 186.3
Total outpatient expenditure 645.3 1,229.6 1,902.8 1,015.1
Inpatient care expenditure
Expenditure per day 327.1 344.4 415.3 344.6
Total inpatient expenditure 10,921.3 7369.1 9,117.6 10,102.1
Totala 11,566.6 8,598.7 11,020.4 11,117.2
Data source: Patient surveys and hospital records
aANOVA for total cost between three counties, p = 0.598, no significant
difference observed in the total expenditure for patients receiving both
outpatient and inpatient care between counties
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patients with extra services and medicines, such as liver
protection drugs, non-free, second-line anti-TB drugs,
and extra tests, which are not on the reimbursable list
approved by the NCMS, nor on the list of free TB ser-
vices. In other words, and as we found in this study,
most TB outpatient service expenses were paid for out-
of-pocket by TB patients. Many studies published in
China and elsewhere support these findings [13, 14].
Expenditure associated with inpatient services is much
higher than that associated with outpatient services. Tu-
berculosis care is no exception. Many papers have re-
ported that Chinese hospitals often maximized revenue
generation through the overprovision of healthcare ser-
vices [15–17]. Hence, it is not surprising that the rates
of hospital admission for TB patients in the three project
sites ranged from 39 % in YZ county to 83 % in DT
county. Hospitalized TB patients often believe that the
NCMS policy partially covers expenses associated with
inpatient services. What they likely did not realize was
that the amount required to pay out-of-pocket, as part
of the deductible and co-insurance payments, would be
much higher than what they were otherwise required to
pay for outpatient services. Our study shows that the
expenditure for only outpatient care was just one-tenth
of what it was for both outpatient and inpatient care,
which is consistent with other studies conducted in both
developed and developing countries [18, 19]. Hospital
admission for patients with uncomplicated TB is not
necessary and should be mitigated or avoided in order to
use resources in a more cost-effective manner. This is
particularly important in settings with limited health
resources.
One thing is clear—the hospitals included in this study
did not follow the national guidelines for TB care and
control in China. They intended to overprovide TB ser-
vices, including overusing second-line anti-TB drugs.
However, they may have had their reasons for this. For
example, healthcare providers at hospitals might have
wanted patients with complications or those experien-
cing side effects related to the use of first-line drugs to
be admitted to hospital, and therefore also administered
second-line anti-TB drugs. However, many published
studies [8–10] and our qualitative findings indicate that
although these might be justifiable reasons for higher hos-
pital admission rates and/or for the overuse of second-line
anti-TB drugs or examinations, the unacceptable financial
incentives given to hospitals in China may be one of the
main factors resulting in this overprovisioning of TB ser-
vices. In the 1980s, with the shrinking of government in-
vestment in public health facilities, public hospitals gained
increasing financial autonomy to generate revenues and
retain surpluses. Meanwhile, salaries of healthcare pro-
viders were tied with revenue generated for facilities
through a bonus system. Since then, free standing public
hospitals have competed for patients by introducing highly
technological medical services, providing comprehensive
diagnostic and laboratory tests, and encouraging patients
to take expensive new drugs, known as the “medical arms
race” [20, 21]. Driven by profit, healthcare providers opted
to provide more and more expensive services.
The overprovisioning of TB care has many implications.
The two chief ones are 1) increased financial burdens
placed on TB patients’ families and health insurance
funds, and 2) compromising the quality of care that may
lead to more drug-resistant patients. Inappropriate and/or
interrupted treatments have been identified as the main
causes for drug-resistant TB development in China, and
are associated with adverse health outcomes [22, 23]. Our
study and other studies in China [8–10] found that sub-
stantial expenditures were incurred by TB patients and
were the result of many non-recommended services,
which have culminated in discontinued treatment due to
difficulty in affording care [24]. Several papers included in
this special issue paint a grave picture of the catastrophic
expenditures incurred by TB patients who have completed
treatment due largely to high out-of-pocket payments. Pa-
tients are at great risk of falling into the vicious disease-
poverty cycle. Moreover, unnecessary medical services will
increase consumption of the pool fund of health insurance
schemes and may take limited resources away from neces-
sary medical service coverage. The overprovisioning of TB
care not only undermines efforts to control TB, but also
results in serious socioeconomic consequences for poor
TB patients.
Conclusion
It appears that the free TB care policy cannot effectively
cover the requirements of diagnosis and treatment for
TB under the integrated model. Both the “free” TB care
policy and the NCMS benefit package do not work
under this model to successfully control TB in Jiangsu,
China, as we have illustrated in this paper. The Chinese
government needs to take action to regulate and im-
prove the rational provisioning of TB care by hospitals
via the development of a sensible mechanism for finan-
cing hospitals. It must also improve the benefit packages
offered by the NCMS, so these can provide more cover-
age for outpatient care. Inaction on these issues could
bring about further grave consequences for TB care and
control in the coming years.
Study strengths and limitations
In this study, we examined the use of and expenditures
associated with TB care based on hospital records, which
is a more accurate method than patient recall. Moreover,
combined quantitative and qualitative data provide holistic
explanations for TB care provision and its implications.
However, there are some limitations. Firstly, the hospital
Jia et al. Infectious Diseases of Poverty  (2016) 5:1 Page 7 of 8
records reflected total medical expenditure for TB treat-
ment, but were not stratified to show how much of the ex-
penditure was reimbursable by health insurance schemes
or how much patients paid out-of-pocket. In addition,
we couldn’t identify 63 of the 263 surveyed TB pa-
tients using the hospital records primarily due to incom-
plete information. The sample size was relatively small
and generalization of results should be done with caution.
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